← Leaderboards
Anton P Porsteinsson
University Of Rochester
$8,737,681
Attributed
$17,157,967
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$17,157,967 · 2
By mechanism
R01$16,840,572 · 1
U01$317,395 · 1
Top collaborators
- Constantine G Lyketsos9 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Kimberly Allison Van Orden$8,637,020
- Ying Meng$462,808
- Feng Vankee Lin$10,046,749
- Jan A Moynihan$13,300,730
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPlacebosCaregiversParticipantPsychosocialS DiseaseBloodSymptomsSafetyAgitationSubgroupCognitionEscitalopramTraitAffectiveIndexingEffective TherapySeveritiesAge GroupAttentionImpaired CognitionAntipsychotic AgentsCognitiveDouble-Blind Method
Grant awards (14)
Escitalopram for Agitation in Alzheimer Disease$2,959,649
R01 · FY2022 · AG
Escitalopram for Agitation in Alzheimer Disease$3,521,438
R01 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease$332,357
R01 · FY2021 · AG
The Coronavirus Pandemic, Caregiver Distress, And Neuropsychiatric Symptoms In Individuals With Alzheimer's Disease$332,237
R01 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease - Actigraph Supplement$379,256
R01 · FY2019 · AG
Escitalopram for Agitation in Alzheimer Disease$3,011,794
R01 · FY2018 · AG
Escitalopram for Agitation in Alzheimer Disease - Blood Biomarker Banking Supplement$120,368
R01 · FY2018 · AG
Escitalopram for Agitation in Alzheimer Disease$3,000,455
R01 · FY2017 · AG
Escitalopram for Agitation in Alzheimer Disease$3,183,018
R01 · FY2016 · AG
Depression in Alzheimer's Disease Study 2 (DIADS-2)$61,110
U01 · FY2007 · MH · contact PI
Depression in Alzheimer's Disease Study 2 (DIADS-2)$62,935
U01 · FY2006 · MH · contact PI
Depression in Alzheimer's Disease Study 2 (DIADS-2)$64,450
U01 · FY2005 · MH
Depression in Alzheimer's Disease Study 2 (DIADS-2)$64,450
U01 · FY2004 · MH
Depression in Alzheimer's Disease Study 2 (DIADS-2)$64,450
U01 · FY2003 · MH